Pharmacological Management of Irritable Bowel Syndrome With Diarrhea
Publication Date: June 21, 2022
Last Updated: April 19, 2023
Summary of Recommendations
Eluxadoline
In patients with IBS-D, the AGA suggests using eluxadoline ( Moderate , Conditional (weak) )
Implementation remark: eluxadoline is contraindicated in patients without a gallbladder or those who drink more than 3 alcoholic beverages per day
612
Title
Pharmacological Management of Irritable Bowel Syndrome With Diarrhea
Authoring Organization
American Gastroenterological Association